VA
VR Adviser Portfolio holdings
AUM
$1.33B
This Quarter Return
+57.13%
1 Year Return
+6.92%
3 Year Return
+862.77%
5 Year Return
+1,580.48%
10 Year Return
–
AUM
$594M
AUM Growth
+$594M
(-8.4%)
Cap. Flow
-$56.5M
Cap. Flow
% of AUM
-9.51%
Top 10 Holdings %
Top 10 Hldgs %
70.57%
Holding
38
New
7
Increased
4
Reduced
6
Closed
10
Top Buys
| 1 |
Axsome Therapeutics
AXSM
|
$51.7M |
| 2 |
Celcuity
CELC
|
$29.5M |
| 3 |
KalVista Pharmaceuticals
KALV
|
$19.7M |
| 4 |
Novavax
NVAX
|
$19.3M |
| 5 |
Merus
MRUS
|
$19M |
Top Sells
| 1 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$94.8M |
| 2 |
Relmada Therapeutics
RLMD
|
$56.2M |
| 3 |
Gossamer Bio
GOSS
|
$20.9M |
| 4 |
Instil Bio
TIL
|
$19.9M |
| 5 |
AKUS
Akouos, Inc. Common Stock
AKUS
|
$18.9M |
Sector Composition
| 1 | Healthcare | 98.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATYR
26
aTyr Pharma
ATYR
$527M
| $2.57M | 0.43% | 1,171,436 -227,453 | -16% | -$498K |
|
|
AFMD
27
DELISTED
Affimed
AFMD
| $1.77M | 0.3% | 1,428,571 | – | – |
|
28
Rallybio
RLYB
$22.4M
| $1.76M | 0.3% | 268,532 | – | – |
|
29
Altimmune
ALT
$338M
| – | – | -369,306 | Closed | -$4.72M |
|
30
Celldex Therapeutics
CLDX
$1.47B
| – | – | -75,000 | Closed | -$2.11M |
|
|
31
Gossamer Bio
GOSS
$562M
| – | – | -1,747,000 | Closed | -$20.9M |
|
32
Immunocore
IMCR
$1.62B
| – | – | -94,605 | Closed | -$4.44M |
|
|
33
Relmada Therapeutics
RLMD
$37.2M
| – | – | -1,518,056 | Closed | -$56.2M |
|
|
34
Instil Bio
TIL
$182M
| – | – | -4,105,779 | Closed | -$19.9M |
|
35
Ventyx Biosciences
VTYX
$171M
| – | – | -207,925 | Closed | -$7.26M |
|
|
RXDX
36
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| – | – | -121,663 | Closed | -$7.18M |
|
|
TCDA
37
DELISTED
Tricida, Inc. Common Stock
TCDA
| – | – | -9,050,064 | Closed | -$94.8M |
|
|
AKUS
38
DELISTED
Akouos, Inc. Common Stock
AKUS
| – | – | -2,800,566 | Closed | -$18.9M |
|